ArticleFrontiers in oncology2022

Neoadjuvant chemotherapy for borderline resectable and upfront resectable pancreatic cancer increasing overall survival and disease-free survival?

Violette Fossaert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.